Malta - English - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - tuberculin purified, protein derivative - solution for injection - tuberculin purified protein derivative 5tu - diagnostic agents

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - gonadotropin releasing factor (gnrf) analogue protein conjugate (vet.) - solution for injection (sc) - formulation: each 2 ml (dose) contains: gonadotropin releasing factor (gnrf) analogue-protein conjugate ... (gnrf conjugated to diphtheria toxoid synthetic peptide analogue) 2300 ug.

Ireland - English - HPRA (Health Products Regulatory Authority)

grifols deutschland gmbh - alpha-1-proteinase inhibitor - powder and solvent for solution for infusion - 1000 milligram(s) - proteinase inhibitors; alfa1 antitrypsin

Ireland - English - HPRA (Health Products Regulatory Authority)

healthilife limited - calcium caseinate soya protein fructose flavour protein hydrolysate lecithinum soya -

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - suspension for injection - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - protein (hbsag) - injection - 10 mcg/ml - protein (hbsag) 10 mcg/ml

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - protein (hbsag) - injection - 40 mcg/ml - protein (hbsag) 40 mcg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - protein c - powder and solvent for solution for injection - 500unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - protein c - powder and solvent for solution for injection - 1000unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

csl behring uk ltd - protein s; factor ii; factor vii; factor ix; factor x; protein c - powder and solvent for solution for injection - 195unit ; 340unit ; 175unit ; 255unit ; 410unit ; 300unit